SYSTEMIC THERAPY IN PANCREATIC CANCER: FROM CYTOTOXIC REGIMENS TO MOLECULARLY TARGETED TREATMENT

Authors

  • Esankulova B.S Samarkand State Medical University Author
  • Normuxammedov D.Sh Samarkand State Medical University Author

Keywords:

Keywords: pancreatic cancer, chemotherapy, FOLFIRINOX, KRAS, PARP inhibitors, precision oncology

Abstract

Most patients with pancreatic cancer present with locally advanced or metastatic disease, making systemic therapy the cornerstone of treatment. Despite incremental progress, durable responses remain uncommon, and the tumor's dense stroma and immunosuppressive microenvironment contribute to treatment resistance.

 

Downloads

Published

2026-10-20